Detalhe da pesquisa
1.
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Future Oncol
; 18(12): 1449-1459, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040698
2.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lancet Oncol
; 22(7): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143969
3.
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.
Future Oncol
; 16(30): 2375-2384, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580579
4.
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 711-718, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922731
5.
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Cancer
; 124(15): 3118-3126, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905927
6.
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
N Engl J Med
; 373(5): 428-37, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222558
7.
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Oncologist
; 22(3): 264-271, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209746
8.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877855
9.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173967
10.
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 23(7): 726-34, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830357
11.
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial.
Lancet Oncol
; 14(13): 1326-36, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231627
12.
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
J Immunother Cancer
; 12(1)2024 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242717
13.
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
J Immunother Cancer
; 12(3)2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485190
14.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Cancer
; 119(24): 4290-8, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122767
15.
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Cancer
; 119(14): 2555-63, 2013 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23605883
16.
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.
J Clin Oncol
; 41(5): 974-979, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608305
17.
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
EClinicalMedicine
; 58: 101917, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090438
18.
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
Oncologist
; 17(12): 1486-95, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23015662
19.
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
Clin Cancer Res
; 28(2): 298-307, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716196
20.
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Cancer Cell
; 40(12): 1537-1549.e12, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400018